What is Wegovy®?
WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity:
- to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.
- that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off.
Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.
It is not known if Wegovy® is safe and effective for use in children under 12 years of age.
It’s administered via a sub-cutaneous injection (under the skin) which in turn reduces your apetite. Wegovy comes as a user-friendly injection pen for self-administration once a week. The drug operates by stimulating receptors in the body which results in a feeling of fullness after eating small amounts of food.
Wegovy is available in various strengths, 0.25mg, 0.5mg,1mg, 1.7mg and 2.4mg and can be purchased privately with valid prescriptions from Gibraltar, UK, Spain and other EU countries.
FOR MORE INFORMATION VISIT THE OFFICAL WEGOVY WEBSITE BELOW: